{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:18:20Z","timestamp":1793171900632,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","award":["81802362"],"award-info":[{"award-number":["81802362"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Tuberculosis (TB) may facilitate carcinogenesis. We performed a case-control study of the association between TB and cancer in Xinjiang, a high TB endemic area of China.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>From January 2016 to December 2018, a total of 45,455 patients hospitalized in Xinjiang Cancer Hospital were consecutively enrolled and divided into a malignant tumor group (<jats:italic>n<\/jats:italic>\u2009=\u200932,539) and a benign tumor group (<jats:italic>n<\/jats:italic>\u2009=\u200912,916). Patients with active and previous TB before the diagnosis of cancer were retrospectively identified in the two groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A significantly higher proportion of TB was found in the malignant tumor group (<jats:italic>n<\/jats:italic>\u2009=\u20091776, 5.46%) than in the control (benign tumor) group (<jats:italic>n<\/jats:italic>\u2009=\u2009175, 1.35%) (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). The highest and lowest proportions of TB in the malignant group were in patients with non-Hodgkin\u2019s lymphoma (16.74%) and thyroid cancer (0.77%), respectively. In multivariate analysis adjusting for age, sex, and ethnicity, TB remained an independent risk factor for all cancers (odds ratio (OR) 1.68; 95% confidence interval (CI) 1.43\u20131.97). Furthermore, TB was associated with a significantly higher risk of non-Hodgkin\u2019s lymphoma, cervical cancer, esophageal cancer, \u201cother\u201d cancers, ovarian cancer, and breast cancer. Moreover, females with TB were more likely to develop cancer than males (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001), except for esophageal cancer and lymphoma.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>TB patients have an elevated cancer risk. A screening strategy for TB should be taken into consideration before treatment in patients with some cancer types that are associated with a high proportion of TB.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-021-08391-6","type":"journal-article","created":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T14:21:46Z","timestamp":1623248506000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Cancer risk in tuberculosis patients in a high endemic area"],"prefix":"10.1186","volume":"21","author":[{"given":"Guang-Liang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun\u2019e","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Mei","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,9]]},"reference":[{"key":"8391_CR1","doi-asserted-by":"publisher","unstructured":"Hershkovitz I, Donoghue HD, Minnikin DE, May H, Lee OY, Feldman M, et al. Tuberculosis origin: the Neolithic scenario. Tuberculosis (Edinb). 2015;95(Suppl 1):S122-6. https:\/\/doi.org\/10.1016\/j.tube.2015.02.021.","DOI":"10.1016\/j.tube.2015.02.021"},{"key":"8391_CR2","unstructured":"Global tuberculosis report 2018. Geneva: World Health Organization; 2018. Licence: CCBY-NCSA3.0IGO."},{"key":"8391_CR3","doi-asserted-by":"publisher","unstructured":"Padayatchi N, Daftary A, Naidu N, Naidoo K, Pai M. Tuberculosis: treatment failure, or failure to treat? Lessons from India and South Africa. BMJ Glob Health. 2019;4(1):e001097. https:\/\/doi.org\/10.1136\/bmjgh-2018-001097.","DOI":"10.1136\/bmjgh-2018-001097"},{"key":"8391_CR4","doi-asserted-by":"publisher","unstructured":"Kyu HH, Maddison ER, Henry NJ, Mumford JE, Barber R, Shields C, et al. The global burden of tuberculosis: results from the global burden of disease study 2015. Lancet Infect Dis. 2018;18(3):261-84. https:\/\/doi.org\/10.1016\/S1473-3099(17)30703-X.","DOI":"10.1016\/S1473-3099(17)30703-X"},{"key":"8391_CR5","doi-asserted-by":"publisher","unstructured":"Houben RM, Dodd PJ. The global burden of latent tuberculosis infection: a re-estimation using mathematical modeling. PLoS Med. 2016;13(10):e1002152. https:\/\/doi.org\/10.1371\/journal.pmed.1002152.","DOI":"10.1371\/journal.pmed.1002152"},{"key":"8391_CR6","doi-asserted-by":"publisher","unstructured":"Mijiti P, Yuehua L, Feng X, Milligan PJ, Merle C, Gang W, et al. Prevalence of pulmonary tuberculosis in western China in 2010-11: a population-based, cross-sectional survey. Lancet Glob Health. 2016;4(7):e485-94. https:\/\/doi.org\/10.1016\/S2214-109X(16)30074-2.","DOI":"10.1016\/S2214-109X(16)30074-2"},{"key":"8391_CR7","doi-asserted-by":"publisher","unstructured":"Qi YC, Ma MJ, Li DJ, Chen MJ, Lu QB, Li XJ, et al. Multidrug-resistant and extensively drug-resistant tuberculosis in multiethnic region, Xinjiang Uygur autonomous region, China. PLoS One. 2012;7(2):e32103. https:\/\/doi.org\/10.1371\/journal.pone.0032103.","DOI":"10.1371\/journal.pone.0032103"},{"issue":"2","key":"8391_CR8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41419-018-1237-y","volume":"10","author":"S Cao","year":"2019","unstructured":"Cao S, Li J, Lu J, Zhong R, Zhong H. Mycobacterium tuberculosis antigens repress Th1 immune response suppression and promotes lung cancer metastasis through PD-1\/PDl-1 signaling pathway. Cell Death Dis. 2019;10(2):44. https:\/\/doi.org\/10.1038\/s41419-018-1237-y.","journal-title":"Cell Death Dis"},{"issue":"10","key":"8391_CR9","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.5588\/ijtld.14.0161","volume":"18","author":"DF Simonsen","year":"2014","unstructured":"Simonsen DF, Farkas DK, Sogaard M, Horsburgh CR, Sorensen HT, Thomsen RW. Tuberculosis and risk of cancer: a Danish nationwide cohort study. Int J Tuberc Lung Dis. 2014;18(10):1211-9. https:\/\/doi.org\/10.5588\/ijtld.14.0161.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"8391_CR10","doi-asserted-by":"publisher","first-page":"11901","DOI":"10.1038\/s41598-019-48395-8","volume":"9","author":"CC Shu","year":"2019","unstructured":"Shu CC, Liao KM, Chen YC, Wang JJ, Ho CH. The burdens of tuberculosis on patients with malignancy: incidence, mortality and relapse. Sci Rep. 2019;9(1):11901. https:\/\/doi.org\/10.1038\/s41598-019-48395-8.","journal-title":"Sci Rep"},{"key":"8391_CR11","doi-asserted-by":"publisher","unstructured":"Kuo SC, Hu YW, Liu CJ, Lee YT, Chen YT, Chen TL, et al. Association between tuberculosis infections and nonpulmonary malignancies: a nationwide population-based study. Br J Cancer. 2013;109(1):229-34. https:\/\/doi.org\/10.1038\/bjc.2013.220.","DOI":"10.1038\/bjc.2013.220"},{"key":"8391_CR12","doi-asserted-by":"publisher","unstructured":"Yu YH, Liao CC, Hsu WH, Chen HJ, Liao WC, Muo CH, et al. Increased lung cancer risk among patients with pulmonary tuberculosis: a population cohort study. J Thorac Oncol. 2011;6(1):32-7. https:\/\/doi.org\/10.1097\/JTO.0b013e3181fb4fcc.","DOI":"10.1097\/JTO.0b013e3181fb4fcc"},{"issue":"1","key":"8391_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13027-017-0143-8","volume":"12","author":"R Everatt","year":"2017","unstructured":"Everatt R, Kuzmickiene I, Davidaviciene E, Cicenas S. Nonpulmonary cancer risk following tuberculosis: a nationwide retrospective cohort study in Lithuania. Infect Agent Cancer. 2017;12(1):33. https:\/\/doi.org\/10.1186\/s13027-017-0143-8.","journal-title":"Infect Agent Cancer"},{"issue":"6","key":"8391_CR14","doi-asserted-by":"publisher","first-page":"757","DOI":"10.5588\/ijtld.15.0783","volume":"20","author":"R Everatt","year":"2016","unstructured":"Everatt R, Kuzmickiene I, Davidaviciene E, Cicenas S. Incidence of lung cancer among patients with tuberculosis: a nationwide cohort study in Lithuania. Int J Tuberc Lung Dis. 2016;20(6):757-63. https:\/\/doi.org\/10.5588\/ijtld.15.0783.","journal-title":"Int J Tuberc Lung Dis"},{"key":"8391_CR15","doi-asserted-by":"publisher","unstructured":"Su VY, Yen YF, Pan SW, Chuang PH, Feng JY, Chou KT, et al. Latent tuberculosis infection and the risk of subsequent Cancer. Medicine (Baltimore). 2016;95(4):e2352. https:\/\/doi.org\/10.1097\/MD.0000000000002352.","DOI":"10.1097\/MD.0000000000002352"},{"issue":"11","key":"8391_CR16","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1086\/503917","volume":"42","author":"M Kamboj","year":"2006","unstructured":"Kamboj M, Sepkowitz KA. The risk of tuberculosis in patients with cancer. Clin Infect Dis. 2006;42(11):1592-5. https:\/\/doi.org\/10.1086\/503917.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"8391_CR17","doi-asserted-by":"publisher","first-page":"e17479","DOI":"10.1371\/journal.pone.0017479","volume":"6","author":"DR Brenner","year":"2011","unstructured":"Brenner DR, McLaughlin JR, Hung RJ. Previous lung diseases and lung cancer risk: a systematic review and meta-analysis. PLoS One. 2011;6(3):e17479. https:\/\/doi.org\/10.1371\/journal.pone.0017479.","journal-title":"PLoS One"},{"key":"8391_CR18","doi-asserted-by":"publisher","unstructured":"Jia Z, Cheng S, Ma Y, Zhang T, Bai L, Xu W, et al. Tuberculosis burden in China: a high prevalence of pulmonary tuberculosis in household contacts with and without symptoms. BMC Infect Dis. 2014;14(1):64. https:\/\/doi.org\/10.1186\/1471-2334-14-64.","DOI":"10.1186\/1471-2334-14-64"},{"key":"8391_CR19","unstructured":"Li XX, Zhang H, Jiang SW, Liu XQ, Fang Q, Li J, et al. Geographical distribution regarding the prevalence rates of pulmonary tuberculosis in China in 2010. Zhonghua Liu Xing Bing Xue Za Zhi. 2013;34(10):980-4."},{"key":"8391_CR20","unstructured":"Xia Y, Xin D, Chen W, Zhang H, Liu X, Xue L, et al. Pulmonary tuberculosis prevalence among different regions in China in. Chinese Journal of Antituberculosis. 2010;2012:803-7."},{"issue":"4","key":"8391_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1258\/td.2009.080348","volume":"39","author":"CE Omoti","year":"2009","unstructured":"Omoti CE, Olu-Eddo AN, Nwannadi AI. Coexistence of TB and adult hematological cancers in Benin City, Nigeria. Trop Doct. 2009;39(4):205-7. https:\/\/doi.org\/10.1258\/td.2009.080348.","journal-title":"Trop Doct"},{"issue":"3","key":"8391_CR22","doi-asserted-by":"publisher","first-page":"286","DOI":"10.21149\/10090","volume":"61","author":"C Molina-Romero","year":"2019","unstructured":"Molina-Romero C, Arrieta O, Hernandez-Pando R. Tuberculosis and lung cancer. Salud Publica Mex. 2019;61(3):286-91. https:\/\/doi.org\/10.21149\/10090.","journal-title":"Salud Publica Mex"},{"key":"8391_CR23","first-page":"3869438","volume":"2021","author":"GL Chen","year":"2021","unstructured":"Chen GL, Xia ZG, Jin J, Yu BH, Cao J. Characterization of artificial pneumothorax-unrelated Pyothorax-associated lymphoma. J Oncol. 2021;2021:3869438.","journal-title":"J Oncol"},{"issue":"8","key":"8391_CR24","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/ni.2060","volume":"12","author":"Y Ben-Neriah","year":"2011","unstructured":"Ben-Neriah Y, Karin M. Inflammation meets cancer, with NF-kappaB as the matchmaker. Nat Immunol. 2011;12(8):715-23. https:\/\/doi.org\/10.1038\/ni.2060.","journal-title":"Nat Immunol"},{"issue":"5","key":"8391_CR25","first-page":"400","volume":"25","author":"DW Kamp","year":"2011","unstructured":"Kamp DW, Shacter E, Weitzman SA. Chronic inflammation and cancer: the role of the mitochondria. Oncology (Williston Park). 2011;25(5):400-10 413.","journal-title":"Oncology (Williston Park)"},{"key":"8391_CR26","doi-asserted-by":"publisher","unstructured":"Qiu L, Huang D, Chen CY, Wang R, Shen L, Shen Y, et al. Severe tuberculosis induces unbalanced upregulation of gene networks and overexpression of IL-22, MIP-1alpha, CCL27, IP-10, CCR4, CCR5, CXCR3, PD1, PDL2, IL-3, IFN-beta, TIM1, and TLR2 but low antigen-specific cellular responses. J Infect Dis. 2008;198(10):1514-9. https:\/\/doi.org\/10.1086\/592448.","DOI":"10.1086\/592448"},{"issue":"Suppl 3","key":"8391_CR27","doi-asserted-by":"publisher","first-page":"S197","DOI":"10.1186\/ar557","volume":"4","author":"AP Cope","year":"2002","unstructured":"Cope AP. Studies of T-cell activation in chronic inflammation. Arthritis Res. 2002;4(Suppl 3):S197-211. https:\/\/doi.org\/10.1186\/ar557.","journal-title":"Arthritis Res"},{"issue":"Suppl 3","key":"8391_CR28","doi-asserted-by":"publisher","first-page":"S100","DOI":"10.1093\/infdis\/jiu147","volume":"209","author":"S Nhamoyebonde","year":"2014","unstructured":"Nhamoyebonde S, Leslie A. Biological differences between the sexes and susceptibility to tuberculosis. J Infect Dis. 2014;209(Suppl 3):S100-6. https:\/\/doi.org\/10.1093\/infdis\/jiu147.","journal-title":"J Infect Dis"},{"issue":"2","key":"8391_CR29","first-page":"115","volume":"49","author":"M Connolly","year":"1996","unstructured":"Connolly M, Nunn P. Women and tuberculosis. World Health Stat Q. 1996;49(2):115-9.","journal-title":"World Health Stat Q"},{"key":"8391_CR30","doi-asserted-by":"crossref","unstructured":"Srivastava K, Kant S, Narain A, Bajpai J. Tuberculosis in women: A reflection of gender inequity. 2018:PA531.","DOI":"10.1183\/13993003.congress-2018.PA531"},{"issue":"5","key":"8391_CR31","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.4049\/jimmunol.1601975","volume":"199","author":"A Keselman","year":"2017","unstructured":"Keselman A, Fang X, White PB, Heller NM. Estrogen signaling contributes to sex differences in macrophage polarization during asthma. J Immunol. 2017;199(5):1573-83. https:\/\/doi.org\/10.4049\/jimmunol.1601975.","journal-title":"J Immunol"},{"issue":"1","key":"8391_CR32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1524-475X.2008.00440.x","volume":"17","author":"CE Routley","year":"2009","unstructured":"Routley CE, Ashcroft GS. Effect of estrogen and progesterone on macrophage activation during wound healing. Wound Repair Regen. 2009;17(1):42-50. https:\/\/doi.org\/10.1111\/j.1524-475X.2008.00440.x.","journal-title":"Wound Repair Regen"},{"issue":"3","key":"8391_CR33","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1365-2567.2011.03488.x","volume":"134","author":"FM Menzies","year":"2011","unstructured":"Menzies FM, Henriquez FL, Alexander J, Roberts CW. Selective inhibition and augmentation of alternative macrophage activation by progesterone. Immunology. 2011;134(3):281-91. https:\/\/doi.org\/10.1111\/j.1365-2567.2011.03488.x.","journal-title":"Immunology"},{"issue":"2","key":"8391_CR34","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.immuni.2013.08.015","volume":"39","author":"D An","year":"2013","unstructured":"An D, Kasper DL. Testosterone: more than having the guts to win the tour de France. Immunity. 2013;39(2):208-10. https:\/\/doi.org\/10.1016\/j.immuni.2013.08.015.","journal-title":"Immunity"},{"key":"8391_CR35","doi-asserted-by":"publisher","unstructured":"Najafi M, Hashemi Goradel N, Farhood B, Salehi E, Nashtaei MS, Khanlarkhani N, et al. Macrophage polarity in cancer: a review. J Cell Biochem. 2019;120(3):2756-65. https:\/\/doi.org\/10.1002\/jcb.27646.","DOI":"10.1002\/jcb.27646"},{"key":"8391_CR36","unstructured":"Bordignon V, Bultrini S, Prignano G, Sperduti I, Piperno G, Bonifati C, et al. High prevalence of latent tuberculosis infection in autoimmune disorders such as psoriasis and in chronic respiratory diseases, including lung cancer. J Biol Regul Homeost Agents. 2011;25(2):213-20."},{"issue":"6","key":"8391_CR37","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1183\/09031936.00222911","volume":"40","author":"K Hemminki","year":"2012","unstructured":"Hemminki K, Liu X, Ji J, Sundquist J, Sundquist K. Effect of autoimmune diseases on risk and survival in histology-specific lung cancer. Eur Respir J. 2012;40(6):1489-95. https:\/\/doi.org\/10.1183\/09031936.00222911.","journal-title":"Eur Respir J"},{"issue":"10","key":"8391_CR38","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.autrev.2017.07.022","volume":"16","author":"E Giat","year":"2017","unstructured":"Giat E, Ehrenfeld M, Shoenfeld Y. Cancer and autoimmune diseases. Autoimmun Rev. 2017;16(10):1049-57. https:\/\/doi.org\/10.1016\/j.autrev.2017.07.022.","journal-title":"Autoimmun Rev"},{"key":"8391_CR39","doi-asserted-by":"crossref","unstructured":"Dobler CC, Cheung K, Nguyen J, Martin A. Risk of tuberculosis in patients with solid cancers and hematological malignancies: a systematic review and meta-analysis. Eur Respir J. 2017;50(2).","DOI":"10.1183\/13993003.00157-2017"},{"key":"8391_CR40","doi-asserted-by":"publisher","unstructured":"Anastasopoulou A, Ziogas DC, Samarkos M, Kirkwood JM, Gogas H. Reactivation of tuberculosis in cancer patients following administration of immune checkpoint inhibitors: current evidence and clinical practice recommendations. J Immunother Cancer. 2019;7(1):239-51. https:\/\/doi.org\/10.1186\/s40425-019-0717-7.","DOI":"10.1186\/s40425-019-0717-7"},{"key":"8391_CR41","unstructured":"World Health Organization. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. Geneva; 2018. https:\/\/pubmed.ncbi.nlm.nih.gov\/30277688\/."},{"key":"8391_CR42","doi-asserted-by":"crossref","unstructured":"Force USPST, Bibbins-Domingo K, Grossman DC, Curry SJ, Bauman L, Davidson KW, et al. Screening for latent tuberculosis infection in adults: US preventive services task Force recommendation statement. JAMA. 2016;316(9):962-9.","DOI":"10.1001\/jama.2016.11046"},{"key":"8391_CR43","doi-asserted-by":"crossref","unstructured":"Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med 2000, 161(4 Pt 2):S221-S247.","DOI":"10.1164\/ajrccm.161.supplement_3.ats600"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08391-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-08391-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08391-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T14:23:46Z","timestamp":1623248626000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-08391-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,9]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8391"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-08391-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,9]]},"assertion":[{"value":"31 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the Xinjiang Medical University Institutional Review Board (number K-2021004). Informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared that no competing interests exist.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"679"}}